Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-17-000811
Filing Date
2017-08-24
Accepted
2017-08-24 17:21:20
Documents
1
Group Members
PETER S. PARK

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G eagle_13gaug142017.htm SC 13G 61861
  Complete submission text file 0000905718-17-000811.txt   63495
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88022 | Film No.: 171049994
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 165 LARKSPUR CA 94939 (415) 524-2902
Park West Asset Management LLC (Filed by) CIK: 0001386928 (see all company filings)

EIN.: 300132084 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G